Pathios Therapeutics
Latest round
- Series B
Last raised
- Apr 2024
Total raised
- $34M
Investors
- 3
About Pathios Therapeutics
Based in Oxford, UK, and founded in 2017 by co-founders Tom McCarthy and Stuart Hughes, Pathios Therapeutics Limited operates as a biotechnology company that engages in research and development of immunotherapy approach for cancers. Pathios Therapeutics Limited provides oncology and immunology solutions for cancer treatment through targeting the acid sensing GPCR, GPR65. The company’s product, PTT-4256, is an orally bioavailable, highly potent, and selective GPR65 inhibitor, designed to reverse the immunosuppressive effects of acidic pH in the TME. It developed human genetics-led research, transcriptomics, and cellular immunology with insights into the underlying causal biology of immune cell dysfunction in cancer. The company's research extends beyond cancer, exploring the potential of GPR65 modulation in other immunological diseases like Inflammatory Bowel Disease and Multiple Sclerosis.
Who invested in Pathios Therapeutics
3 investors across 2 rounds
See all investors in Pathios Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pathios Therapeutics
Who invested in Pathios Therapeutics?
Pathios Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pathios Therapeutics raised?
Pathios Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pathios Therapeutics last raise money?
Pathios Therapeutics's most recent round on record is a Series B, in Apr 2024.
What does Pathios Therapeutics do?
Based in Oxford, UK, and founded in 2017 by co-founders Tom McCarthy and Stuart Hughes, Pathios Therapeutics Limited operates as a biotechnology company that engages in research and development of immunotherapy approach for cancers.
Where is Pathios Therapeutics headquartered?
Pathios Therapeutics is headquartered in Abingdon, UK.
Which VCs invest in companies like Pathios Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Pathios Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pathios Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.